Saturday, August 4, 2012

Elacytarabine For Acute Myeloid Leukemia is on Phase III Study

Elacytarabine is a novel elaidic acid derivative of cytarabine and currently undergoing the CLAVELA phase III study for treatment of patients with relapsed/refractory Acute Myeloid Leukemia (AML). Hope sooner this drug will be out in the market.
The Dutch biotech company Skyline Diagnostics B.V. (Skyline) and the Norwegian drug development company Clavis Pharma ASA (Clavis) disclosed signing a research agreement. Under this agreement, Skyline will investigate gene expression biomarkers for selection of individual Acute Myeloid Leukemia (AML) patients that may benefit from a new AML drug in development at Clavis.
“For Clavis and for elacytarabine this is an important collaboration. Skyline Diagnostics’s expertise will be instrumental in searching for gene expression patterns that can be utilized in the further biomarker program of elacytarabine,” said Athos Gianella-Borradori, CMO of Clavis Pharma.
This genomic approach adds to their currently ongoing patient selection based on protein markers and will deepen their insights into the potential for precise and highly effective personalized medicines. It is their goal and vision that this collaboration with the experts of Skyline will bring better therapies to the many patients suffering from difficult-to-treat leukemia.
“After the successful launch of the AML pro-filer in Europe, we are pleased to further strengthen our companion diagnostics activities,” said Henk Viëtor, CEO of Skyline.
Pharma companies are recognizing the value of companion diagnostics in positioning their drugs. By applying their bio-informatics engine, product development and regulatory experience, they can add substantial value to the process of drug development.
About Skyline Diagnostics B.V. Telephone +31107038410
Skyline Diagnostics develops and markets array-based diagnostic tests for personalized medicine. Skyline’s product the AML pro-filer simplifies AML diagnostics by replacing 7 separate assays by a single micro-array-based test. The company has built strong collaborations with leading scientists and pharmaceutical companies and has several strategic alliances with industrial partners for distribution and manufacturing.
About Clavis Pharma ASA Telephone +4724110950
Clavis Pharma ASA is a late clinical stage oncology discovery and drug development company with a portfolio of novel anti-cancer drugs in development. These patented New Chemical Entities (NCEs) are novel, improved versions of commercially successful drugs, made using Clavis Pharma’s Lipid Vector Technology (LVT) chemistry. Data generated suggests these potential breakthrough products may offer improved efficacy and reduced side effects.
Webmasters, Online Writers Try ZEEF - Filtering The World's Information and to Enhancing Your World Status and Online Connections

Disqus for Wikinut Awesome Publishing Site for Articles

Content.ad - WikinutAwesome 1

Cancer Expert Search

Cancer ExpertCancer Expert: Search
Enter your question and submit. Use a complete English sentence for better results.
Cancer Expert, © 2012-2013, ctSearch - Context Search Engine.
For any reuse or distribution, you must make clear to others the license terms of this work. The best way to do this is with a link to this web page: Wikinut Awesome Where Pen Writes, Win Rewards and Recognitions -

Welcome. Enjoy Your Stay

http://creativecommons.org/licenses/by/3.0/

This blog is safe to hang on. Both young and old, any Nationals: Male and Female – Students, Housewives, Professionals – Domestic and International audience are welcome. Also I would appreciate for your honest comments and suggestions. This blog caters articles about Education, History, Health, Article Marketing, Web Marketing, Bookmarking Sites, Social Networks, Site Reviews, Social Media, Issues, Celebrities, Music, Money, Making Money Online, Business, Business Opportunities, Search Engines Optimization, Music, Science, Self-Improvement, Blog, Blogging, Writing, Writing Tips, Travel, Online Writing, Technology and other things I always love to write under the merciless sun. If there are bloggers and other writers planning to connect with this blog, I would be happy to Welcome Everyone.

Word of The Day

Subscribe on JacketFlap

Add This Blog to the JacketFlap Blog Reader

ppruel @Wikinut

Check Page Rank of your Web site pages instantly:

This page rank checking tool is powered by Page Rank Checker service